686 related articles for article (PubMed ID: 24590289)
21. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
[TBL] [Abstract][Full Text] [Related]
22. Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.
Marinković A; Liu F; Tschumperlin DJ
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):422-30. PubMed ID: 23258227
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Åhrman E; Hallgren O; Malmström L; Hedström U; Malmström A; Bjermer L; Zhou XH; Westergren-Thorsson G; Malmström J
J Proteomics; 2018 Oct; 189():23-33. PubMed ID: 29501846
[TBL] [Abstract][Full Text] [Related]
24. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
26. Matrix abnormalities in pulmonary fibrosis.
Upagupta C; Shimbori C; Alsilmi R; Kolb M
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950306
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix.
Nho RS; Im J; Ho YY; Hergert P
Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(8):L632-42. PubMed ID: 25172912
[TBL] [Abstract][Full Text] [Related]
28. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
29. Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis.
Xia H; Bodempudi V; Benyumov A; Hergert P; Tank D; Herrera J; Braziunas J; Larsson O; Parker M; Rossi D; Smith K; Peterson M; Limper A; Jessurun J; Connett J; Ingbar D; Phan S; Bitterman PB; Henke CA
Am J Pathol; 2014 May; 184(5):1369-83. PubMed ID: 24631025
[TBL] [Abstract][Full Text] [Related]
30. A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts.
Monaghan-Benson E; Wittchen ES; Doerschuk CM; Burridge K
Mol Biol Cell; 2018 Sep; 29(18):2165-2175. PubMed ID: 29995590
[TBL] [Abstract][Full Text] [Related]
31. CircRNA TADA2A relieves idiopathic pulmonary fibrosis by inhibiting proliferation and activation of fibroblasts.
Li J; Li P; Zhang G; Qin P; Zhang D; Zhao W
Cell Death Dis; 2020 Jul; 11(7):553. PubMed ID: 32694556
[TBL] [Abstract][Full Text] [Related]
32. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatic analysis of next‑generation sequencing data to identify dysregulated genes in fibroblasts of idiopathic pulmonary fibrosis.
Sheu CC; Chang WA; Tsai MJ; Liao SH; Chong IW; Kuo PL
Int J Mol Med; 2019 Apr; 43(4):1643-1656. PubMed ID: 30720061
[TBL] [Abstract][Full Text] [Related]
34. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
35. Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.
Tomos IP; Tzouvelekis A; Aidinis V; Manali ED; Bouros E; Bouros D; Papiris SA
Expert Rev Respir Med; 2017 Apr; 11(4):299-309. PubMed ID: 28274188
[TBL] [Abstract][Full Text] [Related]
36. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.
Chen L; Yang Y; Peng X; Yan H; Zhang X; Yin L; Yu H
Aging (Albany NY); 2020 May; 12(9):8339-8351. PubMed ID: 32396525
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of idiopathic pulmonary fibrosis.
Wolters PJ; Collard HR; Jones KD
Annu Rev Pathol; 2014; 9():157-79. PubMed ID: 24050627
[TBL] [Abstract][Full Text] [Related]
39. 3D in vitro hydrogel models to study the human lung extracellular matrix and fibroblast function.
Phogat S; Thiam F; Al Yazeedi S; Abokor FA; Osei ET
Respir Res; 2023 Oct; 24(1):242. PubMed ID: 37798767
[TBL] [Abstract][Full Text] [Related]
40. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
